Welcome New Council Members

We rely on our advisory breast cancer research council for guidance in setting our research priorities, providing effective outreach to CBCRP stakeholders, and making grant-funding decisions. The council is comprised of advocates, scientists, clinicians, nonprofit health representatives, and industry representatives. All of these individuals have provided insightful vision that has shaped the CBCRP into what it is today. Council members serve a three-year term, so each year introduces new changes that ensure that our program continues to develop and grow. Led by a newly-elected chair and vice-chair, Lisa Wanzor and Amy Kyle, respectively, we and the council welcome five new members (who appear below on pages 7 and 8).

Crystal D. Crawford, Esq., serves as CEO of the California Black Women’s Health Project, where she performs legislative, educational, and
policy advocacy to improve the health status of African American women and girls. Throughout her career, she has combined legal and policy approaches to civil rights and social justice issues.
Crystal earned her J.D. from New York University Law School, where she served as an editor of the Journal of International Law & Politics, a Hays-Weber Civil Rights Fellow, and
Chairperson of the Black Law Students
Association. Crystal gained litigation experience as an associate with premier corporate law firms in Los Angeles, Boston, and New York, and
then turned her attention to the nonprofit sector, serving as Legal Director of the Alliance for Children’s Rights. Crystal serves on a variety of boards and councils including Health Access,
VIP Mentors, and California’s Women’s
Health Council.

Diane Griffiths currently serves as Chief Counsel to the California State Assembly Rules Committee. In 1995- 1996, Griffiths served as Chief of Staff to Assemblywoman Barbara Friedman, the author of the legislation that created
the California Breast Cancer Research Program. In 2002, she was herself diagnosed with breast cancer and underwent surgery, chemotherapy, and radiation therapy to treat the disease. She also
has served from 2002-2006 as a Commissioner
of the California Medical Assistance Commission, which administers California’s selective provider contracting program for hospitals serving Medi-Cal patients. She also previously served in a number of legislative positions affecting a broad range of health policy decisions, including efforts to expand access to health care and to secure funding for California’s trauma network. She represented the Assembly on the Managed Health Care Advisory Committee and on the Managed Health Care Improvement Task Force.

Gordon Parry, Ph.D., is currently Head of the Cancer Research Department at Berlex Biosciences in Richmond, California. He has focused his research on utilizing genomics technologies to find new targets for drug development and in discovering small molecule and antibodybased drugs. Prior to joining Berlex, Dr. Parry was head of cancer gene therapy
efforts at Somatix Gene Therapy, (now Cell Genesys), where he developed some of the first cytokine based (GM-CSF) tumor cell vaccines. Prior to his work in the biotechnology sector, Dr. Parry spent 12 years in academic research, mostly
as a Staff Scientist at the University of California’s Lawrence Berkeley Laboratory (LBL). At LBL he made significant contributions to research on the regulation of mammary epithelial cell differentiation and to the discovery of antibodies
targeting breast tumor cells. Dr. Parry obtained his Ph.D. in Biochemistry from the University of London, and carried out post-doctoral work at the University of California, Berkeley.

Klaus Porzig, M.D., received both his undergraduate and Doctor of Medicine degrees at Stanford University, then completed his internship at University of California, San Francisco. He completed his residency in internal medicine and clinical fellowship in medical oncology at Stanford University. He was also a research fellow in the
Laboratory of Cellular and Molecular Biology at the National Cancer Institute. For 27 years he was a partner in Southbay Oncology Hematology Partners in Campbell, California. During the past
ten years he has concentrated on the care of patients with breast cancer. He retired from private practice in September 2006 and continues to practice at the Stanford University cancer center in the Breast Oncology Program. He is an active participant in the teaching program of the Department of Medicine and has received the Russell Lee Teaching Award for Excellence in Clinical Teaching several times.

Catherine Quinn is the Executive Director of the California Health Collaborative. She has provided steadfast leadership to community health efforts
in the Central Valley and throughout the state for more than 20 years. She directed health services for the Fresno County Economic Opportunities Commission and for Urban Indian Health Services, Inc. She is recognized for her program
development skills and credited with the collaborative’s transition from a three-program, nonprofit affiliate of the Hospital Council with an operating budget of less than $500,000 to an independent, Fresno-based, nonprofit public
benefit corporation with more than 20 local, regional, and statewide programs and an annual operating budget of more than $15 million.

There is much more to learn about our advisory council members. Visit our website (www.CABreast-
Cancer.org) to read all of their biographies.